AstraZeneca to resume vaccine trials after ‘potentially unexplained illness’ prompted pause

AstraZeneca announced that it was restarting phase three coronavirus vaccine trials after they were paused when a participant became ill.

The pharmaceutical giant announced the resumption on Saturday after the trials were put on hold on Sunday. The patient in question, a woman, was from the United Kingdom and reportedly suffered a rare spinal cord injury.

AstraZeneca did not disclose further information about the illness in its Saturday statement but said that it was “committed to the safety…

Read Full Article

LEAVE A REPLY

Please enter your comment!
Please enter your name here